Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia

Daniel C. Javitt^*, Robert W. Buchanan, Richard S E Keefe, Robert Kern, Robert P. McMahon, Michael F. Green, Jeffrey Lieberman, Donald C. Goff, John G. Csernansky, Joseph P. McEvoy, Fred Jarskog, Larry J. Seidman, James M. Gold, David Kimhy, Karen S. Nolan, Deanna S. Barch, M. Patricia Ball, James Robinson, Stephen R. Marder